Zobrazeno 1 - 10
of 432
pro vyhledávání: '"M, Krulik"'
Publikováno v:
Medunab, Vol 4, Iss 10, Pp 1-9 (2001)
Autor:
N, Perez, C, Tournigand, M, Mabro, J-L, Molitor, P, Artru, E, Carola, T, André, C, Louvet, M, Krulik, A, de Gramont
Publikováno v:
La Revue de medecine interne. 25(2)
Median survival in advanced colorectal cancer patients treated with 5-fluoro-uracil (5FU) and leucovorin (LV) is between 12 and 18 months. The aim of this study was to evaluate long term survival in this disease.We report here, retrospectively, the s
Publikováno v:
Gastroenterologie clinique et biologique. 25(4)
Meningeal carcinomatosis is an uncommon complication in patients with advanced gastric cancer. We report four cases of meningeal carcinomatosis occurring 18 months (mean) after the diagnosis. The presenting manifestations were headache, visual troubl
Autor:
F, Maindrault-Goebel, A, de Gramont, C, Louvet, T, André, E, Carola, V, Gilles, J P, Lotz, C, Tournigand, M, Mabro, J L, Molitor, P, Artru, V, Izrael, M, Krulik
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 11(11)
Studies of bimonthly 48-hour regimens of high-dose leucovorin (LV) (FOLinic acid), 5-fluorouracil (5-FU) by continuous infusion combined with OXaliplatin (FOLFOX) in pretreated patients with metastatic colorectal cancer suggest that oxaliplatin dose
Autor:
M, Mabro, V, Gilles-Amar, C, Louvet, E, Carola, F, Maindrault-Goebel, A, de Gramont, M, Krulik
Publikováno v:
La Revue de medecine interne. 20(10)
Recent advances in the management of colorectal cancer have improved the quality of life and the survival of patients treated with chemotherapy. In order to define the contribution of chemotherapy in elderly patients, we studied the tolerance and the
Publikováno v:
Presse medicale (Paris, France : 1983). 28(26)
Autor:
M, Krulik
Publikováno v:
Presse medicale (Paris, France : 1983). 27(11)
Publikováno v:
European journal of cancer (Oxford, England : 1990). 34(5)
The addition of leucovorin (LV) to 5-fluorouracil (5-FU) in advanced colorectal cancer has shown improved tumour response rates in many trials, but the optimal LV/5-FU regimen has yet to be determined. Seven studies carried out over the last 12 years
Publikováno v:
Presse medicale (Paris, France : 1983). 26(36)
Autor:
M, Krulik
Publikováno v:
Presse medicale (Paris, France : 1983). 26(10)
Metastasis to the ovary has been estimated occur in 6 to 27.8% of all cancers. The wide variation resulting both from methodology and the small, often microscopic size of these secondary tumors. Many are mucocellular tumors or Krükenberg's tumors (o